DRTS

Alpha Tau Medical Ltd

DRTS.US alphatau.com
Healthcare · Biotechnology
14.43
+0.00 (+0.00%)
USD · NASDAQ
52-week range
3.43
15.17
Trading at 94% of the 52-week range
Market Cap
1.32B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.48
Div. Yield
N/A
% Institutions
8.99%
% Insiders
30.51%

1 Year

+276.8%

3 Year

+332.0%

10 Year

+42.9%
Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Company Information

▼
Company Name
Alpha Tau Medical Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: IL0011839383
CIK: 0001871321
Currency: USD
Full Time Employees: 121
Phone: 972 3 577 4115
Website: alphatau.com
Fiscal Year End: December
IPO Date: Mar 08, 2021
Description:

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Address:

Kiryat HaMada St. 5, Jerusalem, Israel, 9777605

People

▼

Directors & Officers

Name Title Year Born
Mr. Uzi Sofer CEO & Chairman 1970
Mr. Raphi Levy Chief Financial Officer 1985
Mr. Amnon Gat Chief Operations Officer 1975
Mr. Ronen Segal Chief Technology Officer 1973
Dr. Robert B. Den M.D. Chief Medical Officer & Member of Scientific Advisory Board 1979
Prof. Yona Keisari Chief Scientific Officer & Member of Scientific Advisory board 1947
Ms. Rebecca Becker Vice President of legal NA
Ms. Yael Zeiger Corporate Controller 1983

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Gem Investment Advisors, LLC 1.43M Jun 30, 2026 1.55% $11.06 1,161.23%
HighTower Advisors, LLC 874.99K Mar 31, 2026 0.95% $0.01 27.45%
Aquamarine Financial (Cayman) Ltd 721.50K Jun 30, 2026 0.78% $0.50 0.00%
Pier Capital, LLC 691.94K Jun 30, 2026 0.75% $1.15 0.00%
Apella Capital, LLC 382.28K Jun 30, 2026 0.41% $0.07 0.00%
ARK Investment Management LLC 292.13K Mar 31, 2026 0.32% $0.02 0.00%
UBS Group AG 286.69K Mar 31, 2026 0.31% $0.00 1,284.97%
Mariner Wealth Advisors LLC 146.40K Mar 31, 2026 0.16% $0.00 16.96%
Daytona Street Capital LLC 146.11K Jun 30, 2026 0.16% $1.33 0.00%
Kovitz Investment Group Partners, LLC 135.02K Jun 30, 2026 0.15% $0.04 -8.24%
Easterly Investment Partners. 128.59K Jun 30, 2026 0.14% $0.11 20.83%
Jane Street Group LLC 75.54K Mar 31, 2026 0.08% $0.00 0.00%
Geode Capital Management, LLC 53.40K Mar 31, 2026 0.06% $0.00 40.92%
Wells Fargo & Co 49.30K Mar 31, 2026 0.05% $0.00 109.79%
Private Advisor Group, LLC 47.58K Jun 30, 2026 0.05% $0.00 0.00%
Bank of America Corp 41.39K Mar 31, 2026 0.04% $0.00 -6.23%
Satovsky Asset Management LLC 40.71K Mar 31, 2026 0.04% $0.05 -24.06%
Renaissance Technologies Corp 40.46K Mar 31, 2026 0.04% $0.00 0.00%
Citadel Advisors Llc 35.40K Mar 31, 2026 0.04% $0.00 0.00%
Northern Trust Corp 33.33K Mar 31, 2026 0.04% $0.00 -1.22%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core MSCI EAFE ETF 464.45K 0.50% ▲ 0.00% Aug 31, 2026
2 SEB Nordamerikafond Småbolag 275.00K 0.30% ▲ 9.50% Jul 31, 2026
3 Pier Capital Small Cap Growth Equity 247.52K 0.27% ▼ 60.11% Jul 31, 2026
4 iShares MSCI EAFE Small-Cap ETF 204.25K 0.22% ▲ 0.00% Aug 31, 2026
5 Acuitas US Microcap Strategy 198.61K 0.21% ▲ 0.00% Jun 30, 2026
6 ARK Israel Innovative Technology ETF 184.38K 0.20% ▲ 0.00% Aug 31, 2026
7 iShares MSCI Israel ETF 134.22K 0.15% ▲ 0.00% Aug 31, 2026
8 Adara Smaller Companies 129.36K 0.14% ▲ 55.68% Jul 31, 2026
9 Dunham Small Cap Growth N 71.66K 0.08% ▲ 48.44% Jul 31, 2026
10 iShares Core MSCI Total Intl Stk ETF 62.98K 0.07% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $1.32B
EBITDA: $-48.76M
Book Value: $0.48
Earnings/Share: $-1.00
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -25.71%
ROE (TTM): -141.68%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $1.23B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 92.48M
Shares Float: 64.10M
% Insiders: 30.51%
% Institutions: 8.99%
Short % Float: 4.76%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

▼

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-1.23M
Gross Profit
subtotal
$-1.23M
SG&A
adjust
$-8.36M
R&D
adjust
$-30.83M
Other Operating Expense
adjust
$-1.86M
Operating Income
subtotal
$-42.29M
Other / Non-Operating Items
adjust
$-339.00K
Net Income
subtotal
$-42.63M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DRTS.US!